The Growth Investor Daily Brief

The Growth Investor Daily Brief

Download on the App Store

The Growth Investor Daily Brief episodes

  • Axiado, ModifyHealth, Cleerly, and Tenstorrent: Series C+ Funding Highlights and Future Prospects
    Michelle introduces the latest episode of The Growth Investor Daily Brief, focusing on companies that have recently secured Series C+ funding. The episode highlights Axiado's Series C funding and their strategic expansion plans, along with ModifyHealth's Series C success and their outlined growth trajectory. Additionally, Cleerly's innovative AI technology and insights into their Series C funding are discussed. The episode also covers Tenstorrent's impressive Series D round, exploring their future prospects in the industry. Michelle concludes with closing remarks and a call to action, urging listeners to stay updated on the latest trends in startup funding.
    (0:00) Introduction to The Growth Investor Daily Brief
    (0:12) Companies securing Series C+ funding highlights
    (1:21) Axiado's Series C funding and expansion strategy
    (2:11) ModifyHealth's Series C success and growth plans
    (3:38) Cleerly's AI technology and Series C funding insights
    (5:26) Tenstorrent's massive Series D round and future prospects
    (6:56) Closing remarks and call to action
    8 min
  • Tractian, Tenstorrent, and Maze Therapeutics: Series C+ Funding Highlights
    Michelle starts with an introduction and welcome, leading into the latest Series C+ funding highlights. The episode features Tractian's funding achievements, alongside updates on Tenstorrent and Maze Therapeutics. In between, there's a brief mention of the episode's sponsor, Acme Corp. Michelle wraps up with closing remarks, providing listeners with a comprehensive overview of these significant funding developments in the startup ecosystem.
    (0:00) Introduction and welcome
    (0:12) Series C+ funding highlights: Tractian, Tenstorrent, and Maze Therapeutics
    (3:19) Sponsor: Acme Corp
    (5:24) Wrap-up and closing remarks
    6 min
  • OneRail, Tenstorrent, and Maze Therapeutics: Series C+ Funding and Future Plans
    Michelle welcomes listeners to the latest episode of The Growth Investor Daily Brief, diving into recent Series C+ funding updates. The episode covers OneRail's efforts in optimizing last-mile delivery and their funding plans, as well as Tenstorrent's Series D success in the AI chip sector. Additionally, Maze Therapeutics' Series D financing and their future strategic plans are discussed. The episode wraps up with investor insights, providing listeners with essential information to stay informed about the evolving investment landscape.
    (0:00) Welcome to The Growth Investor Daily Brief
    (0:13) Series C+ funding updates: OneRail, Tenstorrent, and Maze Therapeutics
    (0:39) OneRail's optimization of last-mile delivery and funding plans
    (1:21) Tenstorrent's Series D success in the AI chip sector
    (2:22) Maze Therapeutics' Series D financing and future plans
    (5:14) Investor insights and episode wrap-up
    6 min
  • Halcyon and Tenstorrent: Series C and D Funding Rounds & AI Innovation Insights
    Michelle begins with an introduction and highlights recent Series C+ funding rounds. She delves into Halcyon's Series C funding, discussing the company's growth trajectory and strategic initiatives. The episode also covers Tenstorrent's Series D funding round, exploring their AI innovations and future funding plans. Michelle concludes with a call to action, encouraging listeners to stay informed on the latest investment trends shaping the tech industry.
    HELLO

    title

    (0:00) Introduction and Series C+ funding highlights
    (0:21) Halcyon's Series C and Tenstorrent's Series D funding rounds
    (1:44) Tenstorrent's AI innovation and funding plans
    (2:38) Conclusion and call to action
    3 min
  • Eon's $70M Series C Raise: Funding Highlights and Future Plans
    Michelle kicks off the episode with a welcome and introduction, before diving into the latest Series C funding highlights. She focuses on Eon's impressive $70 million raise and discusses the company's future plans and strategic direction. The episode concludes with closing remarks and a call to action for listeners, encouraging them to stay engaged with the latest developments in the investment landscape.
    (0:00) Welcome and introduction by Michelle
    (0:12) Series C Funding Highlights: Eon's $70M Raise and Future Plans
    (1:37) Closing remarks and call to action
    2 min
  • Latest Series C+ Funding Highlights with a Spotlight on Eon
    Michelle welcomes listeners to the latest episode and highlights the latest companies securing Series C+ funding, with a special spotlight on Eon. The episode wraps up with information on how listeners can stay updated with future episodes and developments in the investment landscape.
    (0:00) Welcome to The Growth Investor Daily Brief
    (0:12) Latest companies securing Series C+ funding and spotlight on Eon
    (1:51) Wrap up and how to stay updated
    3 min
  • Series C+ funding highlights: Spectro Cloud and Sirona Medical's latest successes
    Michelle provides an overview of the latest Series C+ funding rounds, focusing on Spectro Cloud's impressive $75 million Series C funding and its strategic growth plans. She discusses the investor interest and industry recognition that Spectro Cloud has garnered. Additionally, Michelle highlights Sirona Medical's $42 million Series C financing, emphasizing the company's product innovation in the healthcare technology sector. The episode concludes with closing remarks and a call to action for listeners.
    (0:00) Introduction to The Growth Investor Daily Brief
    (0:13) Overview of latest Series C+ funding rounds
    (0:21) Spectro Cloud's $75 million Series C funding and growth strategy
    (1:37) Investor interest and industry recognition of Spectro Cloud
    (1:59) Sirona Medical's $42 million Series C financing and product innovation
    (3:24) Closing remarks and call to action for listeners
    4 min
  • Series C+ funding highlights: Halcyon, Lighthouse, Infinitus Systems, and Firefly Aerospace
    Michelle presents updates on Series C+ funding, spotlighting Halcyon, Lighthouse, Infinitus Systems, and Firefly Aerospace. She delves into Lighthouse's Series C achievements with investment insights from KKR, explores Infinitus Systems' transformative AI in healthcare, and examines Firefly Aerospace's journey into Series D funding within the space industry.
    (0:00) Welcome to The Growth Investor Daily Brief
    (0:12) Series C+ funding highlights: Halcyon, Lighthouse, Infinitus Systems, and Firefly Aerospace
    (3:43) Lighthouse's Series C success and KKR's investment insights
    (6:13) Infinitus Systems' AI-enabled healthcare revolution
    (9:57) Firefly Aerospace's launch into Series D funding and space industry
    (12:14) Episode wrap-up and call to action
    13 min
  • Series C funding highlights: Halcyon, Lighthouse, Infinitus Systems, and KoRo Handels GmbH
    Michelle discusses Series C funding updates, highlighting Halcyon, Lighthouse, and Infinitus Systems. She covers Lighthouse's expansion with KKR's backing, Infinitus Systems' AI healthcare innovations, and KoRo Handels GmbH's successful Series C and growth plans.
    (0:00) Introduction to the podcast and host
    (0:29) Series C Funding Highlights: Halcyon, Lighthouse, and Infinitus Systems
    (4:09) Lighthouse's Expansion and KKR's Investment
    (7:12) Infinitus Systems' AI Innovations in Healthcare
    (12:00) KoRo Handels GmbH's Series C Success and Expansion Goals
    (13:44) Conclusion and Preview of the Next Episode
    15 min

About The Growth Investor Daily Brief

From the publisher's feed

Get the latest updates on U.S. startups securing Series C to IPO funding, featuring key deals, top investors, and emerging industries shaping the future.